Essential roles in the Fas ligand in the development of hepatitis

Nature Medicine

Volumn 3, Issue 4, 1997, Pages 409-413

  Kondo, Toru ^a   Suda, Takashi ^a   Fukuyama, Hidehiro ^a,b   Adachi, Masashi ^a,c   Nagata, Shigekazu ^a,b  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; ENDOTOXINS; FAS LIGAND PROTEIN; HEPATIC ENCEPHALOPATHY; HEPATITIS B SURFACE ANTIGENS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; SOLUBILITY; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; MUS MUSCULUS; PROPIONIBACTERIUM ACNES;

EID: 0031002790     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0497-409     Document Type: Article

References (17)

1. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449-1456 (1995).
2. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
3. Hanabuchi, S. et al. Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc Natl. Acad. Sci. USA 91, 4930-4934 (1994).
4. Suda, T. et al. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154, 3806-3813 (1995).
5. Vignaux, F. et al. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181, 781-786 (1995).
6. Kägi, D. et al. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530 (1994).
7. Kojima, H. et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1, 357-364 (1994).
8. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652 (1994).
9. Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279 (1992).
10. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809 (1993).
11. Hoofnagle, J., Carithers, R., Shapiro, C. & Ascher, N. Fulminant hepatic failure: Summary of a workshop. Hepatology 21, 240-252 (1995).
12. Berke, G. The CTL's kiss of death. Cell 81, 9-12 (1994).
13. Rose, N.R. & Bona, C. Defining criteria for autoimmune disease (Witebsky's postulates revisited). Immunol. Today 14, 426-430 (1993).
14. Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541-1554 (1993).
15. Moriyama, T. et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248, 361-364 (1990).
16. Ferluga, J. & Allison, A. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 2, 610-611 (1978).
17. Sato, T. et al. Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J. Leuk. Biol. 53, 144-150 (1993).